Tunitas Therapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Tunitas Therapeutics, Inc.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2015.
The French biotech will set out its stall first in the U.S., where peanut allergy is a major concern, and plans to tackle the life-threatening condition with its transdermal patch without relying on local partners.
This Month's Profile Group: Nanomedicine: Will It Get Big?, features profiles of Blend Therapeutics, Kala Pharmaceuticals, Qualiber, and Uroboros Technologies. Plus these Start-Ups Across Health Care: Ceterix Orthopaedics, Flux Medical, Neuros Medical, and Tunitas Therapeutics.
- Large Molecule
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.